Stockscreener 앱 받기
36.22
0.52%
-0.19
Harmony Biosciences Holdings Inc 주식(HRMY)의 최신 뉴스
Earnings Beat: Is Harmony Biosciences Holdings Inc part of any ETF2025 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Harmony Biosciences Projects WAKIX Revenue to Surpass $1 Billion in 2026 - Sleep Review
Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion - TechStock²
HRMY: WAKIX nears blockbuster status as pipeline and commercial expansion drive growth into 2026 - TradingView — Track All Markets
Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 7.4%Here's Why - MarketBeat
Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Buy Signal: Is Harmony Biosciences Holdings Inc. stock a buy before product launchesEarnings Miss & Precise Entry and Exit Recommendations - Bộ Nội Vụ
Harmony Biosciences projects 2026 WAKIX revenue to exceed $1 billion By Investing.com - Investing.com Nigeria
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs - StreetInsider
Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026 - StreetInsider
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation - Business Wire
J.P. Morgan Healthcare Conference - MarketScreener
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates - MSN
Harmony Biosciences' chief commercial officer sells $551,575 in stock - MSN
Is Harmony Biosciences Holdings Inc. stock positioned well for digital economy2025 AllTime Highs & Verified Stock Trade Ideas - Улправда
Is Harmony Biosciences (HRMY) Pricing Reflect Future Growth After Recent Mixed Share Performance - Yahoo Finance
How to contact the Daily Bulletin - FinancialContent
Assessing Harmony Biosciences (HRMY) Valuation After Fresh Clinical Trial Progress In Rare Neurological Disorders - Sahm
Will Harmony Biosciences Holdings Inc. stock outperform growth indexesNew Guidance & Weekly High Conviction Ideas - ulpravda.ru
Why Harmony Biosciences Holdings Inc. stock attracts high net worth investorsWeekly Trend Recap & Short-Term Trading Alerts - Улправда
Bank Watch: Is Harmony Biosciences Holdings Inc. stock positioned well for digital economyEarnings Performance Report & Fast Exit Strategy with Risk Control - Улправда
Market Wrap: Why Harmony Biosciences Holdings Inc. stock attracts high net worth investorsTrade Ideas & Reliable Price Breakout Signals - Улправда
6 Analysts Have This To Say About Harmony Biosciences Hldgs - Benzinga
Are Strong Financial Prospects The Force That Is Driving The Momentum In Harmony Biosciences Holdings, Inc.'s NASDAQ:HRMY) Stock? - 富途牛牛
Truist Securities Lowers Price Target for HRMY Amidst Current Buy Rating | HRMY Stock News - GuruFocus
HRMY vs. LQDA: Which Stock Is the Better Value Option? - Yahoo Finance
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Harmony Biosciences Holdings, Inc.Common Stock (NQ: HRMY - FinancialContent
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Oklahoma City NewsThe Oklahoman - FinancialContent
Harmony Biosciences Holdings (HRMY) Stock Analysis: A Revenue Growth Powerhouse with 25.66% Upside Potential - DirectorsTalk Interviews
Harmony Biosciences Launches Early Trial of Promising Orexin Agonist - MSN
Market Might Still Lack Some Conviction On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Even After 26% Share Price Boost - 富途牛牛
Top 5 US Stocks To Buy In January 2026 - Investing.com
(HRMY) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
26,279 Shares in Harmony Biosciences Holdings, Inc. $HRMY Acquired by Paradiem LLC - MarketBeat
Exchange Traded Concepts LLC Buys 32,923 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc Stock Analysis and ForecastContrarian Investment Ideas & Big Gains Small Trading - earlytimes.in
Quarterly Trades: What is the fair value of Harmony Biosciences Holdings Inc stock nowTrade Risk Summary & Daily Oversold Stock Bounce Ideas - Bộ Nội Vụ
Why Harmony Biosciences Holdings Inc. stock is popular among millennials2025 Growth vs Value & Daily Market Momentum Tracking - Улправда
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Can Harmony Biosciences Holdings Inc. stock maintain operating marginsJuly 2025 Gainers & Reliable Volume Spike Alerts - Улправда
Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study - MyChesCo
Why Harmony Biosciences Holdings Inc. stock appeals to dividend seekersJuly 2025 Outlook & Verified Chart Pattern Trade Signals - DonanımHaber
Will Harmony Biosciences Holdings Inc. stock outperform value stocksBull Run & Safe Entry Momentum Tips - Улправда
Downgrade Watch: Is Harmony Biosciences Holdings Inc. stock positioned well for digital economyWatch List & Stepwise Swing Trade Plans - DonanımHaber
Dow Update: Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones indexWeekly Trend Summary & Long-Term Growth Plans - Улправда
How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutEarnings Growth Summary & Trade Opportunity Analysis Reports - Улправда
Is Harmony Biosciences Holdings Inc. stock resilient to inflation2025 Winners & Losers & Community Consensus Trade Signals - Улправда
Harmony Biosciences (NASDAQ:HRMY) Trading Down 3.9% After Insider Selling - MarketBeat
Street Watch: Will Harmony Biosciences Holdings Inc. stock outperform international peersJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Aug Wrap: How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutJuly 2025 Breakouts & Technical Entry and Exit Alerts - Улправда
Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones index2026 world cup usa national team qualification young talents low block defense match prediction insights - Улправда
Harmony Biosciences (NASDAQ:HRMY) CEO Sells $1,040,172.63 in Stock - MarketBeat
Harmony Biosciences Holdings CEO Sells All Directly Owned Common Stock - TradingView — Track All Markets
Harmony Biosciences CEO reports option exercise and share sale | HRMY SEC FilingForm 4 - Stock Titan
Harmony Biosciences (HRMY): Evaluating Valuation After New EPX-100 Phase 3 Data and Beacon Biosignals Collaboration - Sahm
Harmony Biosciences partners with Beacon for EEG data in sleep trials - Investing.com Nigeria
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG - Investing News Network
4.73%
0.92%
자본화:
|
볼륨(24시간):